🔗 Permalink

Inventor profile of:

Harald Mischak

City:

Sehnde

Country:

Germany

Published Applications:

29

Last publication date:

2015-12-03

Top Assignees for applications by Harald Mischak

The entities that hold a legal rights for patent applications filed by inventor Mischak Harald:

MOSAIQUES DIAGNOSTICS AND THERAPEUTICS AG 3 Hannover, Germany
Mosaiques Diagnostics and Therapeutics AG 1 Hanover, Germany

Recent patent applications by Mischak Harald

Harald Mischak from Sehnde, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2015-12-03

US20150346150A1

AUTOSOMAL-DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD)

#2 | 2015-09-03

US20150247865A1

Polypeptide Markers for the Diagnosis and Evaluation of Vascular Diseases

#3 | 2015-05-14

US20150133343A1

POLYPEPTIDE MARKERS FOR THE DIAGNOSIS OF PROSTATE CANCER

#4 | 2015-05-07

US20150126405A1

POLYPEPTIDE MARKERS FOR THE EARLY RECOGNITION OF THE REJECTION OF TRANSPLANTED KIDNEYS

#5 | 2015-04-09

US20150099312A1

PROCESS FOR NORMALIZING THE CONCENTRATION OF ANALYTES IN A URINE SAMPLE

#6 | 2015-03-26

US20150087554A1

POLYPEPTIDE MARKERS FOR THE DIAGNOSIS OF ALZHEIMER'S DISEASE

#7 | 2015-03-05

US20150065391A1

POLYPEPTIDE MARKERS FOR DIAGNOSIS AND ASSESSMENT OF HEART FAILURE

#8 | 2015-01-22

US20150024970A1

KIDNEY CELL CARCINOMA

#9 | 2015-01-15

US20150018246A1

POLYPEPTIDE MARKER FOR DIAGNOSING AND ASSESSING VASCULAR DISEASES

#10 | 2014-03-13

US20140073057A1

PROCESS AND MARKERS FOR THE DIAGNOSIS OF KIDNEY DISEASES

#11 | 2014-01-30

US20140027283A1

METHOD AND MARKER FOR THE DIAGNOSIS OF A BILE DUCT STRICTURE AND OF A CHOLANGIOCELLULAR CARCINOMA IN BILE

#12 | 2012-09-27

US20120241321A1

POLYPEPTIDE MARKER FOR DIAGNOSING AND ASSESSING VASCULAR DISEASES

#13 | 2012-05-17

US20120118737A1

Method And Markers For Diagnosing Acute Renal Failure

#14 | 2012-02-16

US20120037507A9

METHOD AND MARKER FOR DIAGNOSIS OF TUBULAR KIDNEY DAMAGE AND ILLNESSES

#15 | 2011-11-17

US20110281364A9

METHOD AND MARKER FOR DIAGNOSING DIABETES MELLITUS

#16 | 2011-02-17

US20110036717A1

METHOD AND MARKER FOR DIAGNOSIS OF TUBULAR KIDNEY DAMAGE AND ILLNESS

#17 | 2010-09-30

US20100248378A1

METHOD AND MARKER FOR DIAGNOSING DIABETES MELLITUS

#18 | 2010-09-09

US20100227411A1

POLYPEPTIDE MARKERS FOR THE DIAGNOSIS OF PROSTATE CANCER

#19 | 2010-08-19

US20100210021A1

PROCESS AND MARKERS FOR THE DIAGNOSIS OF KIDNEY DISEASES

#20 | 2010-08-12

US20100200401A1

Polypeptide Markers for the Early Recognition of the Rejection of Transplanted Kidneys

#21 | 2010-04-22

US20100099196A1

PROCESS FOR NORMALIZING THE CONCENTRATION OF ANALYTES IN A URINE SAMPLE

#22 | 2010-03-11

US20100062537A1

Polypeptide Markers for the Diagnosis and Evaluation of Pelvi-Ureteric Junction Obstruction (PUJO)

#23 | 2010-02-11

US20100036094A1

Polypeptide Markers for the Diagnosis of Alzheimer's Disease

#24 | 2009-12-03

US20090298184A1

Polypeptide Markers for the Diagnosis of Prostate Cancer

#25 | 2008-07-17

US20080169194A1

Polypeptide Marker for the Diagnosis of Ateriosclerosis

#26 | 2007-04-12

US20070082402A1

Device and process for the quantitative evaluation of the polypeptides and markers contained in a sample of body fluid for recognizing pathological conditions

#27 | 2006-12-21

US20060286602A1

Method and markers for the diagnosis of renal diseases

#28 | 2006-09-21

US20060211076A1

Method and device for the qualitative and/or quantitative determination of a protein and/or peptide pattern of a fluid sample, which has been taken from a human or animal body

#29 | 2006-05-18

US20060105367A1

Method and markers for the diagnosis of Graft versus Host Disease (GvHD)

InventorID:

627253 ⎘